[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @bio_clouseau M M posts on X about $nvo, $jnj, $ptgx, $sny the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::43475268/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +38% - X Months XXXXXXX -XXXX% - X Year XXXXXXXXX +70% ### Mentions: XX [#](/creator/twitter::43475268/posts_active)  - X Week XX -XX% - X Month XX +23% - X Months XXX -XX% - X Year XXX +174% ### Followers: XXXXXX [#](/creator/twitter::43475268/followers)  - X Week XXXXXX +0.13% - X Month XXXXXX +0.88% - X Months XXXXXX +3.10% - X Year XXXXXX +5.80% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::43475268/influencer_rank)  ### Social Influence [#](/creator/twitter::43475268/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXX% [currencies](/list/currencies) XXX% **Social topic influence** [$nvo](/topic/$nvo) 1.1%, [$jnj](/topic/$jnj) 1.1%, [$ptgx](/topic/$ptgx) 1.1%, [$sny](/topic/$sny) 1.1%, [$pfe](/topic/$pfe) 1.1%, [$lly](/topic/$lly) #76, [$azn](/topic/$azn) #67, [$crbp](/topic/$crbp) #1, [decent](/topic/decent) #123, [$akro](/topic/$akro) XXXX% **Top accounts mentioned or mentioned by** [@artsstocks](/creator/undefined) [@bambossie81](/creator/undefined) [@learnbiotech](/creator/undefined) [@biotechobserver](/creator/undefined) [@biopharmiq](/creator/undefined) [@avidresearch](/creator/undefined) [@houndcl](/creator/undefined) [@bertrandbio](/creator/undefined) [@nachotrust](/creator/undefined) [@biotechanalysst](/creator/undefined) [@jacobplieth](/creator/undefined) [@bioinvestor24](/creator/undefined) [@pjamess69](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@johnbresnahan](/creator/undefined) [@jq1234t](/creator/undefined) [@byjongardner](/creator/undefined) [@jonathanwosen](/creator/undefined) [@lifescivc](/creator/undefined) [@adamcancryn](/creator/undefined) **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [Johnson & Johnson (JNJ)](/topic/$jnj) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Synthetify (SNY)](/topic/$sny) [Pfizer, Inc. (PFE)](/topic/$pfe) [Eli Lilly and Company (LLY)](/topic/$lly) [AstraZeneca PLC (AZN)](/topic/$azn) [Akropolis (AKRO)](/topic/$akro) [GSK plc (GSK)](/topic/$gsk) [Amgen, Inc. (AMGN)](/topic/$amgn) [Asterix Labs (ASTX)](/topic/$astx) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Prometheus Biosciences, Inc. Common Stock (RXDX)](/topic/$rxdx) [Tourmaline Bio, Inc. Common Stock (TRML)](/topic/$trml) [Cere Network (CERE)](/topic/$cere) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [AbbVie Inc (ABBV)](/topic/$abbv) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) ### Top Social Posts [#](/creator/twitter::43475268/posts) --- Top posts by engagements in the last XX hours "$AKRO $NVO premium with 5/19 considered market speculation start date. $GSK bought Boston on 5/14" [X Link](https://x.com/bio_clouseau/status/1976232130591256759) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-09T10:23Z 20K followers, 3371 engagements "$JNJ doesnt seem too impressed with $PTGX contribution towards the development of its oral IL-23" [X Link](https://x.com/bio_clouseau/status/1922672266455748645) [@bio_clouseau](/creator/x/bio_clouseau) 2025-05-14T15:16Z 20K followers, 22.6K engagements "Huge drop down in efficacy in P3 from the P2 studies and weirdly the Q12W did between than Q4W. OX40L/OX40 ( $AMGN $ASTX) mabs wont trouble Dupi . $SNY down XX% on not being able to compete with dupi" [X Link](https://x.com/bio_clouseau/status/1963524061914398900) [@bio_clouseau](/creator/x/bio_clouseau) 2025-09-04T08:46Z 20K followers, 15.2K engagements "Looks like $MTSR received a numerically better offer from a "party 1" but had to turn it down for regulatory + CVR timeline reasons. The former maybe implying that party X was perhaps $NVO $PFE" [X Link](https://x.com/bio_clouseau/status/1975161235210485788) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-06T11:28Z 20K followers, 40.5K engagements "Wow hail mary for $SPRB . Literally had a month or two" [X Link](https://x.com/bio_clouseau/status/1975261847537217843) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-06T18:08Z 20K followers, 16.3K engagements "I think for me the most interesting part about the Peter Marks move is that $LLY now has an infectious disease focus. Unless immunology got mixed up with ID" [X Link](https://x.com/bio_clouseau/status/1975624010642956708) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-07T18:07Z 20K followers, 7544 engagements "Thats about 1/3 lower than the XX per share for 400M+ from early last year. So was early last year hotter than now" [X Link](https://x.com/bio_clouseau/status/1976203203801907535) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-09T08:28Z 20K followers, 8494 engagements "What is track record of rumored deals on friday that didn't occur the following monday" [X Link](https://x.com/bio_clouseau/status/1977700760566546847) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-13T11:39Z 20K followers, 9121 engagements "So doesnt look like the main event M&A wont happen today which likely means that $JNJ actually believes what it said below about $PTGX. Just wants the share of icotrokinra it doesnt own and ptgx thinks otherwise in terms of valuation" [X Link](https://x.com/bio_clouseau/status/1978055373912207569) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-14T11:08Z 20K followers, 13.3K engagements "What does Stat sig mean in this context Is Akeso just looking at p0.05 or was there a pre defined value that wasn't affected by all the interim looks Isnt this final look going to affect Harmoni OS stat anyway Seems a meaningless point" [X Link](https://x.com/bio_clouseau/status/1960668387933073918) [@bio_clouseau](/creator/x/bio_clouseau) 2025-08-27T11:39Z 20K followers, 8883 engagements "Pretty decent track record for $PFE discards. $RXDX TL1A 11B $CERE neurology discards for 8.7B and now $TRML IL-6 for 1.4B. Impressive R&D team not so much the BD/outlicensing team" [X Link](https://x.com/bio_clouseau/status/1965371071949144499) [@bio_clouseau](/creator/x/bio_clouseau) 2025-09-09T11:05Z 20K followers, 15.6K engagements "How was $IMRX able to raise XXX M including 25M from $SNY when ORR seems similar to gem+NabP Some questionable decisions on the oncology front from SNY" [X Link](https://x.com/bio_clouseau/status/1971147870796677345) [@bio_clouseau](/creator/x/bio_clouseau) 2025-09-25T09:40Z 20K followers, 9224 engagements "$AZN $DSKNY Datroway met both PFS AND OS endpoints in Tropion-breast02 1st line IO ineligible TNBC P3 $GILD 20B ADC Trodelvy still waiting on OS in ASCENT-03" [X Link](https://x.com/bio_clouseau/status/1975112692320096469) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-06T08:15Z 20K followers, 2690 engagements "Party X also interesting mention of "recent internal development"" [X Link](https://x.com/bio_clouseau/status/1975170880096415817) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-06T12:06Z 20K followers, 2628 engagements "$ABBV $GMAB Presentations from X folate targetting ADC's to be presented over next X weeks all with topo-1 1) $LLY LY4170156 @ ESMO 2) $AZN AZD5335 @ ESMO 3) $ZYME @ EORTC" [X Link](https://x.com/bio_clouseau/status/1978044483645096058) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-14T10:25Z 20K followers, 4701 engagements "$TSHA Marketcap almost double that of $NGNE likely based on assumption $ALPMY acquiring the company" [X Link](https://x.com/bio_clouseau/status/1979144508076900796) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-17T11:16Z 20K followers, 9618 engagements "@NachoTrust $RVMD if it means government has pricing power over 6236 its going going to lose a ton of revenue in the long term" [X Link](https://x.com/bio_clouseau/status/1979150910547763387) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-17T11:42Z 20K followers, XXX engagements "$CRBP Decent but early HNSCC data. XX% cORR at both doses. PR says X uPR at high dose including X ongoing but dont see them in swim plot . Some responses ongoing in HNSCC . cORR in cervical at high dose XX% and UC XX% . Median lines of TX = X for all patients so X line more advanced than other recent EGFR data from MRUS JNJ. Is data competitive enough to run a late stage P3 Probably comparable to Hengrui SHR-A2102" [X Link](https://x.com/bio_clouseau/status/1979465997179347086) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-18T08:34Z 20K followers, XXX engagements "$CRBP Decent but early HNSCC data. XX% cORR at both doses. PR says X uPR at high dose including X ongoing but dont see them in swim plot . Some responses ongoing in HNSCC . cORR in cervical at high dose XX% and UC XX% . Median lines of TX = X for all patients so X line more advanced than other recent EGFR data from MRUS JNJ. Is data competitive enough to run a late stage P3 Probably comparable to Hengrui SHR-A2102" [X Link](https://x.com/bio_clouseau/status/1979469258972176438) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-18T08:47Z 20K followers, 15.3K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@bio_clouseau M
M posts on X about $nvo, $jnj, $ptgx, $sny the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +38%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXXXX +70%
Mentions: XX #
- X Week XX -XX%
- X Month XX +23%
- X Months XXX -XX%
- X Year XXX +174%
Followers: XXXXXX #
- X Week XXXXXX +0.13%
- X Month XXXXXX +0.88%
- X Months XXXXXX +3.10%
- X Year XXXXXX +5.80%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% cryptocurrencies XXX% currencies XXX%
Social topic influence $nvo 1.1%, $jnj 1.1%, $ptgx 1.1%, $sny 1.1%, $pfe 1.1%, $lly #76, $azn #67, $crbp #1, decent #123, $akro XXXX%
Top accounts mentioned or mentioned by @artsstocks @bambossie81 @learnbiotech @biotechobserver @biopharmiq @avidresearch @houndcl @bertrandbio @nachotrust @biotechanalysst @jacobplieth @bioinvestor24 @pjamess69 @adamfeuerstein @johnbresnahan @jq1234t @byjongardner @jonathanwosen @lifescivc @adamcancryn
Top assets mentioned Novo-Nordisk (NVO) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX) Synthetify (SNY) Pfizer, Inc. (PFE) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) Akropolis (AKRO) GSK plc (GSK) Amgen, Inc. (AMGN) Asterix Labs (ASTX) Metsera, Inc. Common Stock (MTSR) Prometheus Biosciences, Inc. Common Stock (RXDX) Tourmaline Bio, Inc. Common Stock (TRML) Cere Network (CERE) Gilead Sciences, Inc. (GILD) AbbVie Inc (ABBV) Revolution Medicines, Inc. Common Stock (RVMD)
Top Social Posts #
Top posts by engagements in the last XX hours
"$AKRO $NVO premium with 5/19 considered market speculation start date. $GSK bought Boston on 5/14"
X Link @bio_clouseau 2025-10-09T10:23Z 20K followers, 3371 engagements
"$JNJ doesnt seem too impressed with $PTGX contribution towards the development of its oral IL-23"
X Link @bio_clouseau 2025-05-14T15:16Z 20K followers, 22.6K engagements
"Huge drop down in efficacy in P3 from the P2 studies and weirdly the Q12W did between than Q4W. OX40L/OX40 ( $AMGN $ASTX) mabs wont trouble Dupi . $SNY down XX% on not being able to compete with dupi"
X Link @bio_clouseau 2025-09-04T08:46Z 20K followers, 15.2K engagements
"Looks like $MTSR received a numerically better offer from a "party 1" but had to turn it down for regulatory + CVR timeline reasons. The former maybe implying that party X was perhaps $NVO $PFE"
X Link @bio_clouseau 2025-10-06T11:28Z 20K followers, 40.5K engagements
"Wow hail mary for $SPRB . Literally had a month or two"
X Link @bio_clouseau 2025-10-06T18:08Z 20K followers, 16.3K engagements
"I think for me the most interesting part about the Peter Marks move is that $LLY now has an infectious disease focus. Unless immunology got mixed up with ID"
X Link @bio_clouseau 2025-10-07T18:07Z 20K followers, 7544 engagements
"Thats about 1/3 lower than the XX per share for 400M+ from early last year. So was early last year hotter than now"
X Link @bio_clouseau 2025-10-09T08:28Z 20K followers, 8494 engagements
"What is track record of rumored deals on friday that didn't occur the following monday"
X Link @bio_clouseau 2025-10-13T11:39Z 20K followers, 9121 engagements
"So doesnt look like the main event M&A wont happen today which likely means that $JNJ actually believes what it said below about $PTGX. Just wants the share of icotrokinra it doesnt own and ptgx thinks otherwise in terms of valuation"
X Link @bio_clouseau 2025-10-14T11:08Z 20K followers, 13.3K engagements
"What does Stat sig mean in this context Is Akeso just looking at p0.05 or was there a pre defined value that wasn't affected by all the interim looks Isnt this final look going to affect Harmoni OS stat anyway Seems a meaningless point"
X Link @bio_clouseau 2025-08-27T11:39Z 20K followers, 8883 engagements
"Pretty decent track record for $PFE discards. $RXDX TL1A 11B $CERE neurology discards for 8.7B and now $TRML IL-6 for 1.4B. Impressive R&D team not so much the BD/outlicensing team"
X Link @bio_clouseau 2025-09-09T11:05Z 20K followers, 15.6K engagements
"How was $IMRX able to raise XXX M including 25M from $SNY when ORR seems similar to gem+NabP Some questionable decisions on the oncology front from SNY"
X Link @bio_clouseau 2025-09-25T09:40Z 20K followers, 9224 engagements
"$AZN $DSKNY Datroway met both PFS AND OS endpoints in Tropion-breast02 1st line IO ineligible TNBC P3 $GILD 20B ADC Trodelvy still waiting on OS in ASCENT-03"
X Link @bio_clouseau 2025-10-06T08:15Z 20K followers, 2690 engagements
"Party X also interesting mention of "recent internal development""
X Link @bio_clouseau 2025-10-06T12:06Z 20K followers, 2628 engagements
"$ABBV $GMAB Presentations from X folate targetting ADC's to be presented over next X weeks all with topo-1 1) $LLY LY4170156 @ ESMO 2) $AZN AZD5335 @ ESMO 3) $ZYME @ EORTC"
X Link @bio_clouseau 2025-10-14T10:25Z 20K followers, 4701 engagements
"$TSHA Marketcap almost double that of $NGNE likely based on assumption $ALPMY acquiring the company"
X Link @bio_clouseau 2025-10-17T11:16Z 20K followers, 9618 engagements
"@NachoTrust $RVMD if it means government has pricing power over 6236 its going going to lose a ton of revenue in the long term"
X Link @bio_clouseau 2025-10-17T11:42Z 20K followers, XXX engagements
"$CRBP Decent but early HNSCC data. XX% cORR at both doses. PR says X uPR at high dose including X ongoing but dont see them in swim plot . Some responses ongoing in HNSCC . cORR in cervical at high dose XX% and UC XX% . Median lines of TX = X for all patients so X line more advanced than other recent EGFR data from MRUS JNJ. Is data competitive enough to run a late stage P3 Probably comparable to Hengrui SHR-A2102"
X Link @bio_clouseau 2025-10-18T08:34Z 20K followers, XXX engagements
"$CRBP Decent but early HNSCC data. XX% cORR at both doses. PR says X uPR at high dose including X ongoing but dont see them in swim plot . Some responses ongoing in HNSCC . cORR in cervical at high dose XX% and UC XX% . Median lines of TX = X for all patients so X line more advanced than other recent EGFR data from MRUS JNJ. Is data competitive enough to run a late stage P3 Probably comparable to Hengrui SHR-A2102"
X Link @bio_clouseau 2025-10-18T08:47Z 20K followers, 15.3K engagements